Literature DB >> 22722630

Early IVIg treatment has no effect on post-H1N1 narcolepsy phenotype or hypocretin deficiency.

Stine Knudsen1, Bo Biering-Sørensen, Birgitte R Kornum, Eva R Petersen, Jette D Ibsen, Steen Gammeltoft, Emmanuel Mignot, Poul J Jennum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22722630     DOI： 10.1212/WNL.0b013e31825dce03

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  21 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

Review 2.  Narcolepsy Associated with Pandemrix Vaccine.

Authors:  Tomi Sarkanen; Anniina Alakuijala; Ilkka Julkunen; Markku Partinen
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-01       Impact factor: 5.081

3.  Is it Time for Immunotherapy Trials in Narcolepsy?

Authors:  Andreas Lutterotti
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

Review 4.  Current treatment of selected pediatric sleep disorders.

Authors:  Shannon S Sullivan
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

5.  Listening to the Patient Voice in Narcolepsy: Diagnostic Delay, Disease Burden, and Treatment Efficacy.

Authors:  Kiran Maski; Erin Steinhart; David Williams; Thomas Scammell; Julie Flygare; Kimberly McCleary; Monica Gow
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

6.  Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.

Authors:  Michel Lecendreux; Johanna Berthier; Jennifer Corny; Olivier Bourdon; Claire Dossier; Christophe Delclaux
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

Review 7.  Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment.

Authors:  Lucie Barateau; Roland Liblau; Christelle Peyron; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

Review 8.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

Review 9.  Immunotherapy in Narcolepsy.

Authors:  Maria Pia Giannoccaro; Giombattista Sallemi; Rocco Liguori; Giuseppe Plazzi; Fabio Pizza
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

10.  HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.

Authors:  Fang Han; Ling Lin; Barbara Schormair; Fabio Pizza; Giuseppe Plazzi; Hanna M Ollila; Sona Nevsimalova; Poul Jennum; Stine Knudsen; Juliane Winkelmann; Cristin Coquillard; Farbod Babrzadeh; Tim M Strom; Chunlin Wang; Michael Mindrinos; Marcelo Fernandez Vina; Emmanuel Mignot
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.